Status | Study |
RECRUITING |
Study Name: Biodex Training in Hemodialysis Females With Osteopenia Condition: Hemolysis Date: 2024-01-16 Interventions: women group with a number of 29 women receiving 3-time biodex training per week, every time will be 10 minutes for 12 weeks |
Not yet recruiting |
Study Name: Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease Condition: Haemolysis Neonatal Date: 2017-04-24 Interventions: Drug: intravenous immunoglobulin giving intravenous immunoglobulin to neonates included in inclusion cri |
Not yet recruiting |
Study Name: Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2017-04-24 Interventions: Biological: ALXN1210 Single loading dose on Day 1, followed by regular maintenance dosing beginning on D |
Recruiting |
Study Name: Wise Practice of Chinese Hemodialysis (WISHES) Condition: Haemolyses and Related Conditions Date: 2016-12-21 Interventions: Other: No intervention Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen U |
Recruiting |
Study Name: Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department. Condition: Hemolysis Blood Specimen Collection Date: 2016-11-24 Interventions: Device: Hemolysis Point-of-Care test Hemolysis measurement of plasma using a point of care test to deter |
Recruiting |
Study Name: Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2016-06-23 Interventions: Biological: blood sample |
Completed |
Study Name: Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling Condition: Hemolysis Date: 2015-11-24 Interventions: Other: capillary blood sampling |
Recruiting |
Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) Condition: Warm Antibody Autoimmune Hemolytic Anemia Date: 2015-11-19 Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti |
Not yet recruiting |
Study Name: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment Condition: Autoimmune Hemolytic Anemia Date: 2015-02-13 Interventions: Drug: Interleukine-2 Four courses of IL2 ( [Proleukin, Nov |
Completed |
Study Name: Isoagglutinins in the Development of IVIG-associated Hemolysis Condition: Immunoglobulins, Intravenous Hemolysis Date: 2014-08-29 |